(S,R,S)-AHPC-C3-NH2 is primarily utilized in the field of targeted protein degradation, particularly in the development of PROTACs (Proteolysis Targeting Chimeras). This compound serves as a key ligand that binds to E3 ubiquitin ligases, facilitating the recruitment and subsequent degradation of specific target proteins. Its application is significant in research focused on understanding disease mechanisms, especially in oncology, where it helps in degrading oncogenic proteins that drive cancer progression. Additionally, it is employed in drug discovery to identify and validate novel therapeutic targets by selectively eliminating proteins of interest, offering a powerful tool for studying protein function and developing potential treatments for various diseases.